SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001136261-11-000450
Filing Date
2011-08-02
Accepted
2011-08-02 17:11:17
Documents
15
Period of Report
2011-06-30
Filing Date Changed
2011-08-02

Document Format Files

Seq Description Document Type Size
1 10-Q body10q.htm 10-Q 449439
3 CEO 302 CETIFICATE exh31-1.htm EX-31.1 6640
4 CFO 302 CETIFICATE exh31-2.htm EX-31.2 6657
5 906 CETIFICATE exh32.htm EX-32 2921
6 10-Q form10-q.pdf 10-Q 245213
7 CEO 302 CETIFICATE exhibit31-1.pdf EX-31.1 58607
8 CFO 302 CETIFICATE exhibit31-2.pdf EX-31.2 28412
9 906 CETIFICATE exhibit32.pdf EX-32 55570
16 LOGO logo150x107.jpg GRAPHIC 11093
  Complete submission text file 0001136261-11-000450.txt   2415878

Data Files

Seq Description Document Type Size
10 INSTANCE DOCUMENT npsp-20110630.xml EX-101.INS 189964
11 SCHEMA DOCUMENT npsp-20110630.xsd EX-101.SCH 13681
12 CALCULATION LINKBASE DOCUMENT npsp-20110630_cal.xml EX-101.CAL 36968
13 DEFINITION LINKBASE DOCUMENT npsp-20110630_def.xml EX-101.DEF 7840
14 LABELS LINKBASE DOCUMENT npsp-20110630_lab.xml EX-101.LAB 124600
15 PRESENTATION LINKBASE DOCUMENT npsp-20110630_pre.xml EX-101.PRE 91943
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23272 | Film No.: 111004387
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1